USANA HEALTH SCIENCES INC (USNA) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:USNA - US90328M1071 - Common Stock
USNA Key Statistics, Chart & Performance
The current stock price of USNA is 19.85 USD. In the past month the price increased by 0.56%. In the past year, price decreased by -48.48%.
USNA Latest News, Press Relases and Analysis
USNA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 55.99 | 33.90B | ||
| KVUE | KENVUE INC | 16.21 | 33.30B | ||
| ELF | ELF BEAUTY INC | 24.65 | 4.32B | ||
| BRBR | BELLRING BRANDS INC | 14.24 | 3.70B | ||
| COTY | COTY INC-CL A | 17.47 | 2.90B | ||
| IPAR | INTERPARFUMS INC | 15.51 | 2.61B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.03 | 829.78M | ||
| OLPX | OLAPLEX HOLDINGS INC | 14.25 | 760.47M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.17 | 489.56M | ||
| NATR | NATURES SUNSHINE PRODS INC | 21.89 | 363.03M | ||
| HNST | HONEST CO INC/THE | 44.83 | 299.32M | ||
| SKIN | BEAUTY HEALTH CO/THE | N/A | 187.71M |
Related stock screener links
About USNA
Company Profile
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
Company Info
USANA HEALTH SCIENCES INC
3838 West Parkway Blvd.
Salt Lake City UTAH 84120 US
CEO: Kevin G. Guest
Employees: 1700
Phone: 18019547100
USANA HEALTH SCIENCES INC / USNA FAQ
What does USNA do?
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
What is the current price of USNA stock?
The current stock price of USNA is 19.85 USD. The price decreased by -0.9% in the last trading session.
What is the dividend status of USANA HEALTH SCIENCES INC?
USNA does not pay a dividend.
What is the ChartMill technical and fundamental rating of USNA stock?
USNA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Is USANA HEALTH SCIENCES INC (USNA) expected to grow?
The Revenue of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 8.32% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of USNA stock?
USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 362.66M USD. This makes USNA a Small Cap stock.
Can you provide the upcoming earnings date for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) will report earnings on 2026-02-23, after the market close.
USNA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to USNA. When comparing the yearly performance of all stocks, USNA is a bad performer in the overall market: 94.01% of all stocks are doing better.
USNA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to USNA. USNA has an excellent financial health rating, but there are some minor concerns on its profitability.
USNA Financial Highlights
Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS decreased by -30.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.86% | ||
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| Debt/Equity | 0 |
USNA Forecast & Estimates
6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 100.4% is expected in the next year compared to the current price of 19.85.
For the next year, analysts expect an EPS growth of -32.13% and a revenue growth 8.32% for USNA